Extreme step of FDA

[Guest guest]

You are what you eat!

 

After years of eating chemical soup, do brains start thinking like

mechanical/electrical robots?

 

The Food and Drug Administration (FDA) has taken the rare step of

overruling one of its own advisory panels and has approved the drug

Gemzar (known generically as gemcitabine) for the treatment of

recurrent

ovarian cancer. In the past, FDA decision-makers have generally

followed

the advice of their advisory panels, although they are not legally

bound

to do so. So what happened here? How did this approval decision come

about in spite of the advisory panel's ruling?

 

Read on:

 

http://www.cancerdecisions.com/080606.html

 

--Ralph W. Moss, Ph.D.